The Intersection of Marketing & Security

Transforming Retail Spaces and Providing Actionable Insights

Sponsored
AGORACOM NEWS FLASH

NEW LISTING ALERT!!!

Awakn Life Sciences to Commence Trading on the NEO Exchange Under the Symbol 'AWKN'

  • Strategic focus on developing and delivering psychedelic medicines to treat Addiction.
  • Strong psychedelic drug development pipeline targeting Addiction.
  • First mover advantage for clinics in the UK and the EU with 400m people and CAD$25TR GDP.
  • The leading research and clinical team in the industry focused on using psychedelics to treat Addiction.
  • Multiple scalable revenue streams across drug development and clinical delivery.

Awakn logoset 300x100

Hub On AGORACOM / Corporate Profile / Recent Interview

 

 

Vsblty Groupe Technologies Corp. Links